OBJECTIVE: We propose a modification of the original Guy's Stone Score (GSS) to hold on 20 % of prognostic discrimination among groups which makes this score a more reliable resource for risk assessment in patients undergoing percutaneous nephrolithotomy (PCNL). MATERIAL AND METHODS: Historical cohort of 126 patients undergoing PCNL from December 2010 to November 2014 was included in the survey. Every patient was classified according to the original GSS. For the new classification of Guy Stone Score (GSS-M) all of the subgroups included in the scale were analyzed individually and then ranked from better to worst according to the postoperative stone- free rates (SFRs). This ranking led us to reclassify all the original subgroups, clustering them in three new categories according to their SFRs as subgroups of good, intermediate and poor prognosis, trying to achieve at least 20% of prognostic discrimination among the groups. RESULTS: Hundred and twenty-six PCNL procedures were evaluated, but only 124 were included for statistical analysis and classified based on SFR according to the GSS as follows: 76% for grade 1, 71% for grade 2, 55% for grade 3 and 20% for grade 4. The SFRs were also assessed for the GSS-M obtaining the following predictive values as 93%, 67% and 44% for the good, intermediate and poor prognostic groups, respectively. The prognostic difference among the GSS-M groups was always >20% (p<0.05). CONCLUSION: The original GSS has limitations to predict SFR because of its poor discrimination power among prognostic groups. This rearrangement improves prediction of SFR and better discriminates risk groups in PCNL.
OBJECTIVE: We propose a modification of the original Guy's Stone Score (GSS) to hold on 20 % of prognostic discrimination among groups which makes this score a more reliable resource for risk assessment in patients undergoing percutaneous nephrolithotomy (PCNL). MATERIAL AND METHODS: Historical cohort of 126 patients undergoing PCNL from December 2010 to November 2014 was included in the survey. Every patient was classified according to the original GSS. For the new classification of Guy Stone Score (GSS-M) all of the subgroups included in the scale were analyzed individually and then ranked from better to worst according to the postoperative stone- free rates (SFRs). This ranking led us to reclassify all the original subgroups, clustering them in three new categories according to their SFRs as subgroups of good, intermediate and poor prognosis, trying to achieve at least 20% of prognostic discrimination among the groups. RESULTS: Hundred and twenty-six PCNL procedures were evaluated, but only 124 were included for statistical analysis and classified based on SFR according to the GSS as follows: 76% for grade 1, 71% for grade 2, 55% for grade 3 and 20% for grade 4. The SFRs were also assessed for the GSS-M obtaining the following predictive values as 93%, 67% and 44% for the good, intermediate and poor prognostic groups, respectively. The prognostic difference among the GSS-M groups was always >20% (p<0.05). CONCLUSION: The original GSS has limitations to predict SFR because of its poor discrimination power among prognostic groups. This rearrangement improves prediction of SFR and better discriminates risk groups in PCNL.
Authors: Christian Türk; Aleš Petřík; Kemal Sarica; Christian Seitz; Andreas Skolarikos; Michael Straub; Thomas Knoll Journal: Eur Urol Date: 2015-08-28 Impact factor: 20.096
Authors: Kevin Labadie; Zhamshid Okhunov; Arash Akhavein; Daniel M Moreira; Jorge Moreno-Palacios; Michael Del Junco; Zeph Okeke; Vincent Bird; Arthur D Smith; Jaime Landman Journal: J Urol Date: 2014-08-01 Impact factor: 7.450
Authors: Fabio C Vicentini; Giovanni Scala Marchini; Eduardo Mazzucchi; Joaquim F A Claro; Miguel Srougi Journal: Urology Date: 2014-03-05 Impact factor: 2.649
Authors: Zhamshid Okhunov; Justin I Friedlander; Arvin K George; Brian D Duty; Daniel M Moreira; Arun K Srinivasan; Joel Hillelsohn; Arthur D Smith; Zeph Okeke Journal: Urology Date: 2013-03-26 Impact factor: 2.649
Authors: Jae Wook Chung; Heon Ha; Dong Jin Park; Yun Sok Ha; Jun Nyung Lee; So Young Chun; Tae Gyun Kwon; Bum Soo Kim Journal: Investig Clin Urol Date: 2021-03